Amicus Therapeutics, Inc.

NASDAQ:FOLD

11.3 (USD) • At close September 13, 2024
Bedrijfsnaam Amicus Therapeutics, Inc.
Symbool FOLD
Munteenheid USD
Prijs 11.3
Beurswaarde 3,351,478,300
Dividendpercentage 0%
52-weken bereik 9.02 - 14.57
Industrie Biotechnology
Sector Healthcare
CEO Mr. Bradley L. Campbell M.B.A.
Website https://amicusrx.com

An error occurred while fetching data.

Over Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in

Vergelijkbare Aandelen

Canopy Growth Corporation logo

Canopy Growth Corporation

CGC

4.79 USD

Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc.

FATE

4.02 USD

AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

ABCL

2.75 USD

Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated

CORT

38.11 USD

Allscripts Healthcare Solutions, Inc. logo

Allscripts Healthcare Solutions, Inc.

MDRX

9.25 USD

Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc.

ALHC

11.89 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

25.05 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

1.74 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

33.99 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

26.3 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)